With the global aging population on the rise, the demand for physical rehabilitation is set to increase dramatically. More individuals will require long-term care for chronic conditions, post-surgical recovery, and injury rehabilitation. However, the rehabilitation ecosystem remains highly complex and expensive, often requiring frequent in-person therapy sessions that place a burden on patients, caregivers and healthcare providers.
Rebee Health is tackling this challenge by leveraging wearable sensor technology to revolutionize the rehabilitation experience. Its physiotherapy system enables real-time, remote physiotherapy sessions, making rehabilitation more accessible, cost-effective, and data-driven. At the core of Rebee’s solution is its wearable sensor, which collects patients’ biomechanical data while they perform exercises.
This data is transmitted to the patient application, providing real-time insights on how to perform exercises correctly, when to do them, and tracking progress. Simultaneously, the therapist web portal allows healthcare providers to monitor patients remotely, enabling real-time decision-making and reducing unnecessary in-person visits. By implementing Rebee’s system at scale in Singapore, there is significant potential for cost savings across healthcare institutions.
The startup has enabled over 15,000 remote physiotherapy sessions, and its system has the potential to generate an estimated $86 million in annual savings for day rehabilitation centers by freeing up hospital resources. Additionally, it could drive more than $100 million in potential system savings annually for acute hospitals by reducing face-to-face physiotherapy sessions and shortening hospital waiting times.
Recognizing Rebee Health’s potential to reshape rehabilitation, 1337 Ventures has invested in the startup through its 1337 Capital 1 Fund, furthering its commitment to funding disruptive technology in healthcare.
“As the demand for rehabilitation grows, innovative solutions like Rebee Health’s wearable technology are critical to improving patient outcomes while reducing strain on healthcare systems. We see Rebee as a game-changer in digital physiotherapy, making recovery more accessible, efficient, and scalable,” said Bikesh Lakhmichand, CEO and founding partner of 1337 Ventures.
Rebee Health’s Founder, Lincoln Dacy, shared his excitement about the partnership: “We are thrilled to receive this investment from 1337 Ventures, which will accelerate our ability to scale our technology while strengthening our collaborations with healthcare providers. We are also developing our AI-driven rehabilitation system to automate patient monitoring. While we leverage automation and technology, our core focus remains on ensuring that our solutions are highly patient-centric, delivering intuitive and effective rehabilitation experiences.”
With this funding, Rebee Health aims to expand its wearable rehabilitation solutions to more hospitals, clinics, and direct consumers, develop AI-driven rehabilitation to enhance patient engagement and recovery, and strengthen data insights for remote decision-making to improve patient outcomes and reduce costs.
The 1337 Capital 1 Fund is a sector-agnostic seed-stage fund backed by industry leaders like Suresh Thiru, former COO of JobStreet, and successful startup founders. Designed by entrepreneurs for entrepreneurs, the fund provides early-stage startups with funding, mentorship, and strategic guidance, accelerating the next wave of disruptive innovation.
Startups looking to secure investment from 1337 Ventures can apply to pitch at Pitch Tuesday. Idea stage to MVP stage startups can join our upcoming Alpha Startups Pre-Accelerator (July 2025 Intake).
